| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 5e-06 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 7e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |